-
-
-
-
-
-
-
Pre-Open Stock Movers 12/01: (VBIV) (AMBA) (BOX) Higher; (BTAI) (CTIC) (CRM) Lower (more...)
-
-
-
-
-
-
-
BioXcel Therapeutics (BTAI) Announces FDA Acceptance for Filing of NDA for BXCL501 for the Acute Treatment of Agitation Associated with Schizophrenia and Bipolar Disorders I and II
-
-
14,982 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

